PTPRC and erythroleukemia: Moreover, the proportions of CD4, CD8a, and B220 cells in erythroleukemia spleen also increased significantly in the H-120 treatment group, indicating that H-120 effectively stimulates the immune cells in erythroleukemia mice (Figure 7A,C,D).